Introduction {#S0001}
============

Rational drug use (RDU) is the process of appropriate prescribing, dispensing, and patient use of drugs for diagnosis, prevention, and treatment of diseases.[@CIT0001] It encompasses rational prescribing (good diagnosis practice and good prescribing practice, ie, the process of safe, effective, and economical ordering of drugs for the benefit of the patient), rational dispensing (the process of providing the right drug to the right patient in the right formulation or dosage, proper counseling, clear patient instructions, and good stock-management practice), and rational patient use (patient adherence/compliance).[@CIT0002]--[@CIT0004]

Even though drugs are important components of health care and play a crucial role in saving lives, their use is a complex issue concerning the physician, the dispenser, and the patient as a whole. The World Health Organization (WHO) has developed indicators to evaluate the practice of RDU in health facilities.[@CIT0002] These indicators are most often prescribing, health-facility, and patient-care indicators. According to the WHO, inappropriate prescribing and dispensing of medicines accounts for \>50% of all medicines in the market and irrational use of medicines by patients results in various forms of health risks and costs.[@CIT0005]

Irrational use usually arises from multiple prescribing and dispensing errors.[@CIT0006] The period that the dispenser has contact with the patient is an important factor that affects the quality of the patient-care process. As such, it is highly recommended that dispensers/pharmacists have sufficient time for proper counseling and dispensing of drugs to patients so that patients will have clear understanding of how to take medications and significantly improve drug adherence.[@CIT0003],[@CIT0007] Moreover, self-medication by patients is another cause of irrational DU.[@CIT0003]

Inappropriate use of drugs is a common problem, especially in developing countries, substantially contributing to deleterious effects on health and economic burden. Therefore, this study was aimed at investigating the practice of RDU by using WHO DU indicators in Dessie Referral Hospital (DRH), in order to identify the extent of the problem, improve RDU practice, and provide information for further investigation.

Methods {#S0002}
=======

Study Area, Design, and Period {#S0002-S2001}
------------------------------

DRH is the only public referral and teaching hospital in northeast Ethiopia --- in Amhara regional state, South Wollo administrative zone --- 401 km from Addis Ababa, the capital of Ethiopia. Currently, the hospital serves about 7 million patients. An institution-based, retrospective, cross-sectional study design was employed was used to evaluate prescribing indicators, while a prospective approach was employed for patient-care and facility indicators to assess the practice of RDU based on WHO core DU indicators in DRH. The study was conducted from February 2019 to May 2019.

Study Population {#S0002-S2002}
----------------

The study population comprised all those for whom prescriptions were dispensed in the outpatient pharmacy from February 2019 to May 2019 (prescribing indicators), whereas patient attendants and their outpatient prescriptions in daytime working hours from February 2019 to May 2019 were assessed for patient-care indicators. Drugs available most commonly and in Ethiopia\'s 2013 Essential Drug List (EDL) were considered as facility indicators.

Sample-Size Determination and Sampling {#S0002-S2003}
--------------------------------------

### Prescribing Indicators {#S0002-S2003-S3001}

Based on WHO recommendations, 500 prescription encounters were taken from a total of 15,360 prescriptions that were dispensed in the hospital outpatient pharmacy from February 2019 to May 2019.[@CIT0002] With systematic random sampling, 500 outpatient prescriptions were selected by taking every thirty prescription in DRH. Average number of drugs per encounter, percentage of generic drugs prescribeds, percentage of prescriptions with antibiotics, percentage of prescriptions with injections, and percentage of prescribed drugs from EDL were determined.

### Patient-Care Indicators {#S0002-S2003-S3002}

The WHO recommends that at least outpatient attendants (encounters) be included for a health facility.[@CIT0002] For a more reliable result, 150 patients were assessed by prospective convenient sampling. Only one outpatient pharmacy with five windows through which drug dispensating and consultation were done by five pharmacists every day was found.

### Health-Facility Indicators {#S0002-S2003-S3003}

Every health facility must have a minimum of 20 essential drugs.[@CIT0002] In this study, to make the percentage availability of these drugs more feasible, 30 essential drugs were selected ([Table 1](#T0001){ref-type="table"}). The drugs were selected based on the information that these key drugs are commonly used to manage top ten diseases of a hospital and are part of EDL of 2013 of Ethiopia.Table 1Key Essential Drugs Selected in DRH in- and Outpatient Pharmacies as Health-Facility Indicator, February 1 to May 30, 2019 (n=30)**Selected Drugs**Antacids oral suspensionDoxycycline 100 mg capsuleCimetidine 200 mg/mL injectionMetronidazole 250 mg capsuleHydralazine 20 mg/mL, 2 mL injectionCotrimoxazole 480 mg tabletFurosemide 10 mg/mL, 2 mL injectionArtemether + lumefantrineAdrenaline 0.1%, 1mLQuinine injectionAmlodipine 5 mg tabletHydrocortisone injectionDiclofenac 50 mg tabletPropylthiouracil 100 mg tabletAmitriptyline 25 mg tabletGlibenclamide 5 mg tabletDiazepam 5 mg/mL injectionInsulin NPH 100 U/mL injectionPhenobarbitone 30/100mg tabletMetformin 500 mg tabletAmoxicillin 500 mg tablet, 250 or 125 mg/5 mL suspensionOxytocin 10 U/mL injectionAmoxicillin + clavulanic acidFerrous sulfate 300 mgAzithromycin 500 mg tabletOral rehydration saltCeftriaxone 1 g intravenous injectionLactated Ringer's solutionCiprofloxacillin 500 mg tabletNormal saline

### Data-Collection Tools {#S0002-S2003-S3004}

A structured observational checklist was used to collect data on prescribing, facility, and patient-care indicators. Consultation and dispensing times were determined using a stopwatch. Face-to-face interview were usedto collect data on patient knowledge of correct drug information.

### Data Quality Control {#S0002-S2003-S3005}

Training was provided to the data collectors and supervisors on how to collect and organize data. Frequent checks on the data-collection process to ensure completeness and consistency of the data collected were made. Pretesting of the data-collection instruments was done in Boru Meda Hospital, Dessie.

### Data Processing and Analysis {#S0002-S2003-S3006}

Data were entered, processed, and analyzed using SPSS 20. In addition, WHO guidelines were used to evaluate the data explored in this study.

Results {#S0003}
=======

Sociodemographic Characteristics {#S0003-S2001}
--------------------------------

A total of 150 patients participated in the study to evaluate patient-care indicators, of which 63 (42%) were age range of 25--34 years. Males numbered 92 (61.3%), and 66 (44%) patients had completed primary school ([Table 2](#T0002){ref-type="table"}).Table 2Sociodemographic Characteristics of Patients in DRH OPP Interviewed for Patient-Care Indicators, February 1 to May 30, 2019VariablesNumber of PatientsPercentageAge (years)18--242516.6725--34634235--443221.3\>453020SexMale9261.3Female5838.67EducationIlliterate2818.7Primary school6644Secondary school4228College and above149.3

Prescribing Indicators {#S0003-S2002}
----------------------

A total of 1,251 drugs were prescribed from 500 prescriptions by physicians (general practitioners, specialists, and subspecialists). The majority of the prescription encounters contained two drugs (224, 44.8%), followed by three drugs (159, 31.8%; [Figure 1](#F0001){ref-type="fig"}). It was found that an average of 2.5 drugs per encounter were prescribed. In addition, generics were used in 453 (90.53%) prescriptions, and 414 (82.83%) drugs from the EDL were prescribed. Furthermore, 173 (34.64%) prescriptions contained one or more antibiotics, and 69 (13.80%) injections were prescribed ([Table 3](#T0003){ref-type="table"}).Table 3Frequencies and Percentages of Prescribing Indicators in DRH, Eastern Amhara, Ethiopia, February 0 to May 30, 2019 as per WHO CriteriaPrescribing IndicatorsFrequencyPercentageWHO Standard**Generic d**rugs prescribed with generic name45390.53100%Drugs prescribed from EDL41482.83100%Antibiotics prescribed17334.64\<30 (20%--26.8%)Injections prescribed6913.80(13.4%--21.1%)**Average drugs per prescription 2.5 (1,**251 drugs/500 encounters)≤2 (1.6%--1.8%) Figure 1Distribution of drugs prescribed per encounter in DRH outpatient pharmacy from February 1 to May 30, 2019.

Patient-Care Indictors {#S0003-S2003}
----------------------

Average consultation and dispensing times in the present study were 1.57 minutes and 47 seconds, respectively. From a total of 362 drugs prescribed, 299 (82.6%) were actually dispensed, of which only 22.7% were adequately labeled ([Table 4](#T0004){ref-type="table"}). From a total of 150 patients interviewed, 112 (74.67%) correctly responded and had adequate knowledge on how to take the medications ([Table 5](#T0005){ref-type="table"}).Table 4Average Dispensing and Consultation Times and Percentage of drugs dispensed and Labeled in DRH OPP from February 1 to May 30, 2019Patient-Care IndicatorsAverage Dispensing TimeAverage Consultation TimeTotal Drugs PrescribedTotal Dispensed DrugsTotal Labeled Drugs47 seconds1.57 minutes362299 (82.6%)68 (22.7%)WHO standards\>180 seconds10 minutes---100%100% Table 5Patient Knowledge of How to Take Correct Dosage in DRH OPP from February 1 to May 30, 2019Patients InterviewedPatients Taking Correct DosagePercentage15011274.67

Health-Facility Indictors {#S0003-S2004}
-------------------------

The health facility has drug formularies and uses the EDL, but has no standard treatment guidelines (STGs). During the study period, all key essential drugs included in the study were available, except propyl thiouracil ([Table 1](#T0001){ref-type="table"}).

Discussion {#S0004}
==========

Prescribing Indicators {#S0004-S2001}
----------------------

The average number of drugs per encounter in the current study was 2.5, which is higher than the standard set by the WHO (1.6--1.8).[@CIT0002] A similar study done in selected public hospitals of eastern Ethiopia, Bule Hora Hospital, and southern Ethiopia of eight hospitals showed that an average 2.34±1.08, 2.33, and 2.2 (1.7--2.7) drugs per encounter were prescribed, respectively, almost comparable with the present study.[@CIT0008]--[@CIT0010] However, the result of the present study was higher than a study done in Jimma University Specialized Hospital (1.7).[@CIT0011] The observed likelihood of overprescribing drugs beyond the standard in the setting might be related to lack of adequate knowledge and training of health-care professionals and empirical prescribing and symptomatic treatment approaches. These prescribing habits may seriously affect health care by increasing drug interactions, adverse drug reactions, patient noncompliance, overuse and wastage of drugs, and increased patient costs for drugs, among others.[@CIT0002]

In the current study, the proportion of generic drugs prescribed was found to be 90.53%, which is comparable to a study done in selected public hospitals of eastern Ethiopia (90.61%).[@CIT0008] This result was lower than the WHO standard (100%)[@CIT0002] and Bule Hora Hospital (96.8%).[@CIT0009] However, it was higher than studies conducted in southern Ethiopia of eight hospitals (78%)[@CIT0010] and Jimma University Specialized Hospital (87.15%).[@CIT0011] Even though the figure is large, as the study was conducted in a governmental hospital, a considerable number of prescriptions were prescribed by brand, significantly causing money wastage, due to purchasing branded drugs and difficulty of accessing these drugs.[@CIT0002] Prescription of some branded drugs in the study may have been due to doctors\' linkage with drug promoters and business groups. The large health-care practice in Dessie attracts different business groups and drug promoters that galvanize the pharmaceutical market in the study area.

The proportion of antibiotic prescriptions was 34.64%, slightly higher than the WHO standard, which states that \<30% of prescriptions should contain one or more antibiotics.[@CIT0002] This finding was also higher than the finding of studies conducted in Zimbabwe (29%),[@CIT0012] Jimma University Specialized Hospital (25.6%),[@CIT0011] and the United Arab Emirates (9.8%),[@CIT0013] but comparable with a study conducted in Latin American countries that showed the percentage of antibiotics prescribed was 27%--39%.[@CIT0001] However, the result of the present study was lower than the 63% in a study done in Sudan,[@CIT0014] 57.87% in selected public hospitals in eastern Ethiopia,[@CIT0008] 56% in Uganda,[@CIT0015] and 48% in Nigeria.[@CIT0016] Even though prescription of antibiotics in this study was generally acceptable compared to the WHO standard and other studies, overuse and irrational use of antibiotic has become a serious potential threat, due to the rapid emergence of antimicrobial resistance and the slow pace in the discovery and development of new antibacterial agents.

The proportion of encounters with injections in the present study was 13.8%, slightly higher than the WHO core DU-indicator standard (\<10% of prescriptions should include injections)[@CIT0002] and the study done in selected public hospitals of eastern Ethiopia (10.9%).[@CIT0008] However, it was better than studies conducted in other parts of Ethiopia, such as 15% in southern Ethiopia (eight hospitals)[@CIT0010] and 20.3% in Bule Hora Hospital.[@CIT0009] There was a slight elevation from the WHO standard, which might have been due to prevalence of diabetic patients for whom insulin injection was commonly used and some sexually transmitted diseases being treated by ceftriaxone injection (gonorrhea) and 2.4 million U benzathine penicillin G (syphilis) in the hospital outpatient department.

Patient-Care Indicators {#S0004-S2002}
-----------------------

The time that prescribers and dispensers spend with each patient sets important limits on the potential quality of diagnosis and treatment. In the present study, the average times taken for consultation and dispensating of medicines were 1.57 minutes and 47 seconds, respectively. The average consultation time was considered very short (less than the 10 minutes of the WHO standard),[@CIT0002] and shorter than in other studies. A cross-sectional study done in selected public hospitals of eastern Ethiopia showed that average consultation and dispensing times were 4.61 minutes and 61.12 seconds, respectively.[@CIT0008] A study done in Bule Hora Hospital, southern Ethiopia showed an average consultation time of 5.50 minutes and average dispensing time of 1.22 minutes.[@CIT0009] Average consulting time in ten countries was 4.0 minutes,[@CIT0017] and average dispensing time in seven 105 seconds.[@CIT0018] Very short dispensating and consultation times in this study area might be due to high patient load because of the availability of only one outpatient pharmacy for the large catchment population. Very short dispensing times definitely affect appropriate labeling and provision of drug information, thereby increasing patient nonadherence.

From the prescribed medications in this study, only 82.6% drugs were actually dispensed, of which 22.7% were adequately labeled, far lower than the WHO standard (100%), while an average of 89% medicines were dispensed (12 countries) and 54% adequately labeled (eight countries) in other studies.[@CIT0017],[@CIT0018] The current study showed better than one done in selected public hospitals of eastern Ethiopia, which showed that only 75.77% of prescribed drugs were actually dispensed and 3.3% adequately labeled.[@CIT0008] Writing the patient's name and generic name of the drug, expired date, strength, dosage, and total quantity of the drug on the label is necessary to help in reducing dispensing errors.

Regarding patient knowledge of correct dose and frequency, the present study highlighted that about 74.67% of interviewed patients correctly repeated the dose and frequency of each drug dispensed to them. This finding was almost in line with studies done in public hospitals of eastern Ethiopia (75.7%)[@CIT0008] and Bule Hora Hospital (73.3%).[@CIT0009] Knowledge of the patient is a very central factor in the therapeutic process. Even though the current study addressed dose and frequency to assess knowledge of patients, there should be comprehensive assessment of knowledge of side effects of drugs, drug interactions, drug--food interactions, names of dispensed medications, durations, and reason for taking the drug.

Health-Facility Indicators {#S0004-S2003}
--------------------------

The hospital has a national drug formulary and EDL, but no STGs. The WHO recommends the use of an EDL, STGs, and formulary for effective health delivery.[@CIT0002] In one study conducted in nine facilities, 78% had an EDL.[@CIT0001] However, in Ecuador only 38% of facilities had an EDL.[@CIT0005] On the other hand, except propyl thiouracil, all key essential drugs included in the study were available, which meant about 96.7% of key essential drugs were in stock during the study period. Essential medicines satisfy the precedence of health-care needs of the population and should be adequately available at all times. Careful selection of a limited range of essential medicines has several advantages in the supply, prescribing, cost, and patient use of medicines. All of these are even more important in resource-poor settings, where the availability of drugs in the sector is often erratic.[@CIT0019],[@CIT0020]

Limitations of the Study {#S0005}
========================

Evaluating RDU in health facilities based on WHO core DU indicators is critical to find major problem areas in the patient-care process. This study revealed actual gaps in RDU, but did not undertake qualitative investigation of the underlying causes of the problems in a hospital and failed to study whether prescribed drugs were in accordance with the diagnosis. Moreover, the study period was short and should be extended to 6, 9, or 12 months for better and valid evaluation of RDU.

Conclusion {#S0006}
==========

Some RDU practices were not appropriate as evaluated by WHO core DU indicators, and especially more problematic with patient-care indicators. The average number of drugs per prescription and percentage of encounters dispensing antibiotics and injections were slightly above WHO recommendations, while the percentage of generic drugs prescribed was slightly lower than the WHO standard. Average consultation and dispensing times provided to patients at the pharmacy were found to be very short. Not all medications prescribed were dispensed within the hospital, substantialnumbers of drugs were not adequately labeled, and almost a quarter of patients were found to have inadequate knowledge about the correct dose and frequency of their medications. Moreover, the hospital had its own EDL and drug formulary, but no STGs, and most of the key essential drugs were in stock. Although the WHO benchmark for RDU was not met for all indicators, generally the study area is relatively good, especially with respect to most prescribing and health-facility indicators, though still requiring interventions in order to improve the practice of RDU.
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